INF-γ 874 A/T | L. major 102 (%) | Healthy human controls 199 (%) |
Genotypes | ||
AA | 28 (27.5) | 76 (38.2) |
AT | 59 (57.8) | 111 (55.8) |
TT | 15 (14.7) | 12 (6.0) |
Alleles | ||
A | 115 (56.4) | 263 (66.1) |
T | 89 (43.6) | 135 (33.9) |
Statistics | ||
TT + AT vs. AA (dominant) | P = 0.2 | OR (95%CI)1.4 [0.8 to 2.4] |
TT vs. AA+AT (recessive) | P* = 0.02 | OR (95%CI) 2.7 [1.2 to 5.9] |
T allele vs. A allele | p* = 0.02 | OR (95%CI)1.5 [1.07 to2.13] |
INF-γ 874 A/T | L. tropica 59 (%) | Healthy human controls 199 (%) |
Genotypes | ||
AA | 18 (30.5) | 76 (38.2) |
AT | 33 (56) | 111 (55.8) |
TT | 8 (13.5) | 12 (6.0) |
Alleles | ||
A | 69 (58.5) | 263 (66.1) |
T | 49 (41.5) | 135 (33.9) |
Statistics | ||
TT + AT vs. AA (dominant) | P = 0.3 | OR (95%CI)1.4 [0.8 to 2.6] |
TT vs. AA+AT (recessive) | p = 0.06 | OR (95%CI) 2.4 [0.9 to 6.2] |
T allele vs. A allele | p = 0.1 | OR (95%CI)1.4 [0.9 to 2.1] |
INF-γ 874 A/T | L. infantum/ donovani complex 8 (%) | Healthy human controls 199 (%) |
Genotypes | ||
AA | 3 (37.5) | 76 (38.2) |
AT | 4 (50) | 111 (55.8) |
TT | 1 (12.5) | 12 (6.0) |
Alleles | ||
A | 10 (62.5) | 263 (66.1) |
T | 6 (37.5) | 135 (33.9) |
Statistics | ||
NA | NA | NA |
INF-γ 874 A/T | Totalleishmania 169(%) | Healthy human controls 199 (%) |
Genotypes | ||
AA | 49 (29) | 76 (38.2) |
AT | 96 (56.8) | 111 (55.8) |
TT | 24 (14.2) | 12 (6.0) |
Alleles | ||
A | 194 (57.4) | 263 (66.1) |
T | 144 (42.6) | 135 (33.9) |
Statistics | ||
TT + AT vs. AA (dominant) | P = 0.06 | OR (95%CI) 1.5 [1.0 to 2.3] |
TT vs. AA+AT (recessive) | p* = 0.01 | OR (95%CI) 2.5 [1.2 to 5.3] |
T allele vs. A allele | p* = 0.02 | OR (95%CI) 1.4 [1.07 to2.0] |